Chong Kun Dang Pharmaceutical Corp. (185750.KS) KSC

Currency In KRW

AD

Valuation

Market Cap1.09T
Enterprise Value1.24T
P/E Ratio11.5
PEG Ratio0.44
Price/Sales Ratio0.5
Price/Book Ratio0.9
Enterprise/Revenue0.6
Enterprise/EBITDA9.46

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.04
Operating Margin0.04
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.08

Income Statement

Revenue1.69T
Revenue/Share128,937.05
Gross Profit517.23B
EBITDA125.37B
Net Income77.83B
Diluted EPS5,845.54

Balance Sheet

Total Cash285.23B
Total Cash/Share20,664.08
Total Debt368B
Total Debt/Equity0.36
Current Ratio2
Book Value Per Share74,533.06

Price History

52-Week Change-18.81
52-Week High98,100
52-Week Low63,000
Moving Average 50 Days70,748
Moving Average 200 Days82,397

Statistics

Average Volume30,508
Shares Outstanding13.18M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate500
Trailing Annual Dividend Yield0.75
Payout Ratio0.18
Last Split Factor21:20
Last Split DateDecember 27, 2024
AD